Bobby Sahachartsiri is an associate in the firm's Boston office who focuses his practice on patent prosecution in the biotechnology and life sciences industries.
Prior to joining Lathrop Gage, Bobby served as an attorney for a New York City intellectual property law firm. He has experience drafting patent applications and responses to office actions in the U.S., as well as drafting instructions on how to proceed with prosecution in foreign jurisdictions.
During law school, Bobby worked as an intellectual property consultant for a clinical-stage public biotechnology company, where he managed a global patent portfolio, which included over 400 patents and applications of 43 patent families in the areas of antibody mimetics, immuno-oncology, and respiratory diseases. He also prepared new patent applications, developed worldwide filing and prosecution strategy, and oversaw day-to-day prosecution matters. As a Student Attorney in the Vaccine Injury Litigation Clinic, he advocated and represented petitioners in trial proceedings before the U.S. Court of Federal Claims. Bobby was also an editorial staff member on the American Intellectual Property Law Association Quarterly Journal.
Bobby’s scientific research experience spans several laboratories and a broad range of disciplines, including molecular biology, cell biology, immunology, biochemistry, and synthetic biology. He was actively engaged in scientific research at University of California – Los Angeles, University of California – San Francisco, and the National Institutes of Health (NIH) in Bethesda, Maryland.
- New York
- U.S. Patent and Trademark Office
- Editorial Staff Member, AIPLA (American Intellectual Property Law Association) Quarterly Journal, 2015-2017
- NIH Intramural Research Training Award, 2007-2009
- UCSF Summer Research Training Program, 2006 & 2007
- Genentech Foundation, 2007
- Phi Beta Kappa, 2007
- University of California Leadership Excellence through Advanced Degrees Program (UC LEADS) Scholar/Research Fellowship, 2005-2007
- NIH Biomedical Science Enrichment Program (BISEP), 2004
- NIH Fellowships, 2003-2005
- New York Intellectual Property Law Association
- New York State Bar Association
- American Bar Association
- American Intellectual Property Law Association
- Sigma Xi Scientific Honor Society
- American Society for Biochemistry and Molecular Biology (ASBMB)
Author, “The Patent Eligibility of Therapeutic Proteins.” AIPLA QJ 45 (2017): 165.
First Author, “A synthetic biochemistry system for the in vitro production of isoprene from glycolysis intermediates.” Protein Sci., Feb 2014
Co-Author, “Dieselzymes: development of a stable and methanol tolerant lipase for biodiesel production by directed evolution.” Biotechnol Biofuels, May 2013
Co-Author, “Differential regulation of adipocyte PDE3B in distinct membrane compartments by insulin and the beta3-adrenergic receptor agonist CL316243: effects of caveolin-1 knockdown on formation/maintenance of macromolecular signaling complexes.” Biochem J., Dec 2009
- Presenter, “Identiﬁcation of PDE3B Interacting Proteins Involved in the Assembly of Insulin-induced Macromolecular Complexes in 3T3-L1 Adipocytes.” Spring Research Festival, National Institutes of Health, 2009
- Presenter, “Testing In Situ PCR as a Detection Method to Analyze MicroRNA Expression in the Mouse Blastocyst.” Summer Research Training Program Poster/Oral Session, University of California San Francisco, 2007
- Presenter, “Identification of Protein Binding Partners of Ezrin during B Cell Activation.” Sigma Xi Annual Meeting, Detroit, MI, 2006 (Excellent Poster Award)
- Presenter, “Nerve Growth Factor (NGF) and Receptor Tyrosine Kinase A (trkA) mRNA Colocalize in the Zebra Finch Brain.” Koret UC LEADS Symposium, University of California Los Angeles, 2006
28 State StreetSuite 700Boston, MA 02109
George Washington University Law School, J.D., 2017
University of California – Los Angeles, M.S. Biochemistry and Molecular Biology, 2013
University of California – Los Angeles, B.S. Molecular, Cell & Developmental Biology, summa cum laude, 2007